These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carvedilol for heart failure. Med Lett Drugs Ther; 1997 Sep; 39(1010):89-91. PubMed ID: 9323960 [No Abstract] [Full Text] [Related]
5. Using carvedilol to treat heart failure. Taccetta-Chapnick M Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943 [No Abstract] [Full Text] [Related]
6. COMET: a proposed mechanism of action to explain the results and concerns about dose. Hjalmarson A; Waagstein F Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544 [No Abstract] [Full Text] [Related]
7. Carvedilol [Coreg]. Kukin M Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163 [No Abstract] [Full Text] [Related]
8. Carvedilol: use in chronic heart failure. Doughty RN; White HD Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454 [TBL] [Abstract][Full Text] [Related]
9. Carvedilol offers women with heart problems the same clinical benefits as men. Cardiovasc J S Afr; 2002; 13(2):84. PubMed ID: 12166361 [No Abstract] [Full Text] [Related]
10. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Morgan T Clin Pharmacokinet; 1994 May; 26(5):335-46. PubMed ID: 7914479 [TBL] [Abstract][Full Text] [Related]
11. Role of carvedilol controlled-release in cardiovascular disease. Fonarow GC Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256 [TBL] [Abstract][Full Text] [Related]
12. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential. Cheng J; Kamiya K; Kodama I Cardiovasc Drug Rev; 2001; 19(2):152-71. PubMed ID: 11484068 [TBL] [Abstract][Full Text] [Related]
14. [Place of beta blockaders in the treatment of heart failure]. Pornin M; Van Viet H Ann Cardiol Angeiol (Paris); 1998 Dec; 47(10):753-6. PubMed ID: 9922855 [No Abstract] [Full Text] [Related]
15. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Kopecky SL Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583 [TBL] [Abstract][Full Text] [Related]
16. Carvedilol: a countermeasure to heart failure. Barkman A; Pooler C Dimens Crit Care Nurs; 2001; 20(5):11-6. PubMed ID: 22076514 [TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure. Feuerstein G; Ruffolo RR Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976 [No Abstract] [Full Text] [Related]
19. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol. Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524 [TBL] [Abstract][Full Text] [Related]
20. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer]. MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195 [No Abstract] [Full Text] [Related] [Next] [New Search]